To our community: Due to circumstances surrounding COVID-19, Clinical Research IO had to make the difficult decision to discontinue funding for Caretalk. We've decided to leave the website up as a resource for the community. Thank you so much to everyone who made this possible, and please enjoy!

Find Clinical Trials
for Type 2 Diabetes

  • Filter By Keyword
  • Recruiting Status
  • Location
1 - 10 >
Trial Condition Sponsor Status Start Date Location Follow
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Bexagliflozin in Subjects With Type 2 Diabetes Mellitus Who Are Not Adequately Controlled by Metformin Alone Type 2 Diabetes Theracos Enrolling 11/28/2017 Chicago, IL | Chicago, IL | Chicago, IL
timi58-declare Type 2 Diabetes Astrazeneca Pharmaceuticals Enrolling Tomball, TX | Chicago, IL
An Open-label, 2-Period, Fixed-sequence, Phase 1 Study in Healthy Volunteers to Evaluate the Effect of Itraconazole, a Potent CYP3A Inhibitor, on the Pharmacokinetics of IW-1973 Type 2 Diabetes Ironwood Pharmaceuticals Enrolling 4/12/2018 Cambridge, MA | Cambridge, MA | Greer, SC
A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Add-on Study of MLR 1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy Type 2 Diabetes Melior Pharmaceuticals Enrolling 9/1/2017 Cambridge, MA | Hialeah, FL
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Dose Cohort Study to Evaluate the Efficacy and Safety of Twelve Once-weekly Subcutaneous Doses of PB-119 to Patients With Type 2 Diabetes Mellitus (T2DM) Not Well-controlled by Metformin Monotherapy Type 2 Diabetes PegBio Enrolling 6/13/2018 Cambridge, MA | High Point, NC
A Randomized, 26-week, Open-label, 2-treatment Arm, Parallel Group Multicenter Study Comparing the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed-ratio Combination (Soliqua™) Titrated Using a Simple Titration Algorithm (One Unit Daily Adjustment) Compared With Insulin Glargine/Lixisenatide Fixed-ratio Combination (Soliqua™) Titrated by Weekly Adjustment in Patients With Type 2 Diabetes Mellitus (T2DM) Type 2 Diabetes Sanofi Pasteur, Inc. Enrolling 3/11/2019 Cambridge, MA
Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Clinical Trial Type 2 Diabetes Novo Nordisk Enrolling 7/13/2018 | Avon, IN | Avon, IN | Avon, IN | Avon, IN | Avon, IN | Dayton, OH
Effect of Semaglutide Versus Placebo on the Progression of Renal Impairment in Subjects With Type 2 Diabetes and Chronic Kidney Disease Type 2 Diabetes Novo Nordisk Enrolling 6/17/2019 | Pembroke Pines, FL
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes Type 2 Diabetes Lilly, Eli And Company Enrolling 7/30/2019 Springfield, MO | Surprise, AZ | Pembroke Pines, FL
A Randomized, Double-blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Three Tirzepatide Doses Versus Placebo in Patients With Type 2 Diabetes, Inadequately Controlled With Diet and Exercise Alone Type 2 Diabetes Lilly, Eli And Company Enrolling 6/3/2019 | Surprise, AZ | Corvallis, OR
1 - 10 >

Don't See Your
Research Study Here?
Add It To Caretalk!

Related Articles from Researchers & Patients